The presence of Staphylococcus aureus, particularly MRSA, has been associated with adverse clinical outcomes in early life, including lower weight-for-height percentiles, poorer nutritional status, and a greater likelihood of progression from CFTR-related metabolic syndrome (CRMS) to a confirmed diagnosis of CF. This evidence concerns the gene CFTR and cystic fibrosis.